Abstract

NANO DRUG DELIVERY IN CARDIOVASCULAR SYSTEM

*Sorabh Dangi and Devendra

.

Abstract

The life and health of people are now seriously threatened by cardiovascular diseases (CVDs). Despite the fact that there are numerous medicines with various modes of action that are commercially available as traditional formulations for the treatment of CVDs, these medications still fall short of expectations due to issues with water solubility, biological effectiveness, non-targeting, and drug resistance. To increase the efficacy and safety of therapeutic agents, as well as to increase the signal-to-noise ratio of imaging agents, the employment of a drug delivery system (DDS) is always required. Additionally, as the use of nanomaterials expands, so does the risk of exposure in clinical settings. As a result, nanomaterials will have a greater chance of interacting with blood vessels, blood, and their constituent parts, which will have a significant effect on human health. This article focused mostly on introducing the various NDDS kinds, their targeting approaches, and their use in CVDs.

Keywords: .